NM_000639.3:c.466A>G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000639.3(FASLG):c.466A>G(p.Arg156Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,613,510 control chromosomes in the GnomAD database, with no homozygous occurrence. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000639.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000678 AC: 17AN: 250848Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135628
GnomAD4 exome AF: 0.000117 AC: 171AN: 1461276Hom.: 0 Cov.: 33 AF XY: 0.000109 AC XY: 79AN XY: 726980
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74382
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome type 1 Uncertain:1Other:1
- -
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 156 of the FASLG protein (p.Arg156Gly). This variant is present in population databases (rs80358238, gnomAD 0.01%). This missense change has been observed in individual(s) with autosomal dominant autoimmune lymphoproliferative syndrome (PMID: 17605793). ClinVar contains an entry for this variant (Variation ID: 21212). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FASLG protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects FASLG function (PMID: 17605793). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Lung cancer;C1328840:Autoimmune lymphoproliferative syndrome type 1 Uncertain:1
- -
FASLG-related disorder Uncertain:1
The FASLG c.466A>G variant is predicted to result in the amino acid substitution p.Arg156Gly. This variant was reported in the heterozygous state in an individual with autoimmune lymphoproliferative syndrome (Reported as A530G, Bi et al. 2007. PubMed ID: 17605793). Additional functional studies showed that this variant produced a protein that bound to wild-type protein, but prevented it from effectively inducing apoptosis (Bi et al. 2007. PubMed ID: 17605793; Bleesing et al. 1993. PubMed ID: 20301287). This variant is reported in 0.010% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at